Sheila S. Boston is a trial lawyer and litigation strategist who defends clients from initiation of the case through trial and/or settlement. Most recently, New York Governor Andrew Cuomo appointed Ms. Boston to serve a three-year term on New York’s First Department Judicial Screening Committee.
Ms. Boston is valued by her clients for her advocacy skills, dependability, and collaborative spirit. She has successfully litigated before both state and federal courts, with significant MDL experience in mass tort actions, providing litigation avoidance counseling, and conducting audits to evaluate the potential product-related liabilities in proposed corporate acquisitions and reorganizations. She helps her clients by assessing litigation risks and defending lucrative products by weeding out frivolous individual personal injury lawsuits, defending against class actions and mass torts, and devising creative settlement solutions. Adept in “battle of the experts” litigation, Ms. Boston has served as national coordinating counsel of experts, involving the retention, development and preparation of experts for depositions, Daubert/Frye hearings and trials. She has worked with experts in various fields of medicine and science such as toxicology, infectious diseases, epidemiology, oncology, urology, hepatology, endocrinology, cardiology, psychology, and psychiatry. Notably, Ms. Boston is a passionate advocate of diversity and inclusion in the workplace, and she recently received the Chambers Diversity Awards USA 2016 inaugural award for her "Outstanding Contribution to Furthering the Advancement of Diversity in the Legal Profession, Private Practice."
- Bayer Corporation, as co-trial counsel, in a personal injury action in the Philadelphia Court of Common Pleas involving the drug Yasmin, a birth control pill; settled favorably.
- Takeda, as co-trial counsel, in a personal injury action in the Philadelphia Court of Common Pleas involving the drug Actos, a diabetes medication; plaintiff verdict with low damages settled during appeal process.
- Darryl Scott Stinski, as co-trial counsel, in a pro bono post-conviction death penalty proceeding tried before a judge inside of a maximum security Georgia state prison; still pending. Stinski v. State of Georgia
- Secondment Participant in Trial Rotation Program, New York City Law Department, Tort Division, served as trial counsel for Bronx Tort Division for 9/3/13-1/10/14.
- Pfizer, as co-trial counsel, in the Rezulin (diabetes drug) Litigation in mass tort litigation including MDL in SDNY, class actions in U.S. and Canada, and state coordinated proceedings as well as individual actions. Served as co-trial counsel in Mississippi and Alabama state cases and National Coordinator of Experts.
- Sodexho, Inc., as co-trial counsel, in a promotion discrimination class action brought on behalf of over 2,400 African-American mid-level manager plaintiffs; resolved favorably in US$80 million settlement with injunctive relief.
Depositions at NDDLA
Life Sciences, New York (2014, 2016)
Product Liability Defense, New York (2012-2017)
- JD, Columbia Law School, 1993, Topics Editor, Journal of Law and Social Problems
- AB, Princeton University, Woodrow Wilson School of Public Policy and International Affairs, 1990
- New York
- Supreme Court of the United States
- US Court of Appeals for the Second Circuit
- US District Court, Southern District of New York
- US District Court, Eastern District of New York
NY Governor Appointee/Member, New York’s First Department Judicial Screening Committee
Co-Chair, Pro Bono Committee, Kaye Scholer
Vice President, New York City Bar Association
Vice Chair, DRI’s Drug and Medical Device Seminar
Treasurer, Federal Bar Council Foundation
Chair, Minority Partners in Majority Firms Division, National Bar Association
Member, The City of New York Bar Association
Member, New York State Bar Association
Member, American Bar Association
Member, Federal Bar Council (FBC)
Member, National Bar Association
Member, Metropolitan Black Bar Association
Member, New York Bar Foundation Fellow
Member, Defense Research Institute (DRI)